Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961



 Company News
Keryx Biopharmaceuticals (KERX) Announces Fourth Quarter And Year-End 2014 Financial Results 2/27/2015 7:37:49 AM
Keryx Biopharmaceuticals (KERX) To Host Conference Call On Fourth Quarter And Year End 2014 Financial Results 2/18/2015 8:04:54 AM
Keryx Biopharmaceuticals (KERX) Announces Pricing Of $110 Million Public Offering Of Common Stock 1/22/2015 7:35:55 AM
Keryx Biopharmaceuticals (KERX) Announces $100 Million Proposed Public Offering Of Common Stock 1/21/2015 7:32:05 AM
Keryx Biopharmaceuticals (KERX) Announces Transition Of Leadership 1/12/2015 7:55:48 AM
Keryx Biopharmaceuticals (KERX) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 10:07:32 AM
Newly-Approved Keryx Biopharmaceuticals (KERX) Drug Poised to Take About $600 Million of Genzyme Corporation (GENZ)'s Sales 12/31/2014 6:03:43 AM
Keryx Biopharmaceuticals (KERX) Announces Commercial Launch Of AURYXIA™ (Ferric Citrate) Tablets In The United States 12/22/2014 8:01:46 AM
Keryx Biopharmaceuticals (KERX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014 8:14:35 AM
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Auryxia (Ferric Citrate) Covering Orally Administrable Forms 12/4/2014 4:37:33 PM